Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988





 Company News
Acceleron Pharma To Present Luspatercept Clinical Trials At The 20th Congress Of The European Hematology Association 5/22/2015 6:35:51 AM
Acceleron Pharma To Present Dalantercept Clinical Data At The 2015 ASCO Annual Meeting 5/14/2015 12:21:29 PM
Acceleron Pharma Reports First Quarter 2015 Financial And Operational Results 5/7/2015 12:52:27 PM
Acceleron Pharma Release: Luspatercept Data Presented At The 13th International Symposium On Myelodysplastic Syndromes 5/4/2015 10:30:19 AM
Celgene (CELG) And Acceleron Pharma Select Luspatercept To Advance To Phase 3 In Myelodysplastic Syndromes 4/30/2015 9:57:27 AM
Acceleron Pharma To Host First Quarter 2015 Financial Results Conference Call And Webcast On May 7, 2015 4/28/2015 12:01:38 PM
Acceleron Pharma To Present At Upcoming Investor Conferences In May 4/23/2015 10:22:40 AM
Acceleron Pharma Announces Oral Presentations Of Luspatercept And Sotatercept Data At The 13th International Symposium On Myelodysplastic Syndromes 4/7/2015 10:42:23 AM
Acceleron Pharma Appoints Dr. Francois Nader As Chairman Of Its Board Of Directors 4/6/2015 10:24:59 AM
Acceleron Pharma Announces Executive Appointments And Promotions 3/6/2015 7:51:41 AM